These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 27709447)

  • 1. Current views on HIV-1 latency, persistence, and cure.
    Melkova Z; Shankaran P; Madlenakova M; Bodor J
    Folia Microbiol (Praha); 2017 Jan; 62(1):73-87. PubMed ID: 27709447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells.
    Sluis-Cremer N
    Curr Top Med Chem; 2016; 16(10):1191-7. PubMed ID: 26324046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding a cure for HIV: will it ever be achievable?
    Lewin SR; Evans VA; Elliott JH; Spire B; Chomont N
    J Int AIDS Soc; 2011 Jan; 14():4. PubMed ID: 21255462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutics for HIV-1 reactivation from latency.
    Sgarbanti M; Battistini A
    Curr Opin Virol; 2013 Aug; 3(4):394-401. PubMed ID: 23810462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
    Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Didehydro-Cortistatin A: a new player in HIV-therapy?
    Mousseau G; Valente ST
    Expert Rev Anti Infect Ther; 2016; 14(2):145-8. PubMed ID: 26581953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV eradication: combinatorial approaches to activate latent viruses.
    De Crignis E; Mahmoudi T
    Viruses; 2014 Nov; 6(11):4581-608. PubMed ID: 25421889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of latency reversal agents in the cure of HIV: A review of current data.
    Bashiri K; Rezaei N; Nasi M; Cossarizza A
    Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.
    Battistini A; Sgarbanti M
    Viruses; 2014 Apr; 6(4):1715-58. PubMed ID: 24736215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Persistence, Latency, and Cure Approaches: Where Are We Now?
    Chou TC; Maggirwar NS; Marsden MD
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waking up the sleepers: HIV latency and reactivation.
    Mok HP; Lever A
    J Formos Med Assoc; 2008 Dec; 107(12):909-14. PubMed ID: 19129050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A broad drug arsenal to attack a strenuous latent HIV reservoir.
    Stoszko M; Ne E; Abner E; Mahmoudi T
    Curr Opin Virol; 2019 Oct; 38():37-53. PubMed ID: 31323521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models.
    Bricker KM; Chahroudi A; Mavigner M
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights into HIV-1 Persistence in Sanctuary Sites During Antiretroviral Therapy.
    Poveda E; Tabernilla A
    AIDS Rev; 2016; 18(1):55. PubMed ID: 27028272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of finding a cure for HIV infection.
    Richman DD; Margolis DM; Delaney M; Greene WC; Hazuda D; Pomerantz RJ
    Science; 2009 Mar; 323(5919):1304-7. PubMed ID: 19265012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological strategies to target HIV persistence.
    Martrus G; Altfeld M
    Curr Opin HIV AIDS; 2016 Jul; 11(4):402-8. PubMed ID: 27054281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which therapeutic strategy will achieve a cure for HIV-1?
    Cillo AR; Mellors JW
    Curr Opin Virol; 2016 Jun; 18():14-9. PubMed ID: 26985878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors.
    Jean MJ; Fiches G; Hayashi T; Zhu J
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):1-24. PubMed ID: 30351168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.